ALAN HICKS: Open Payments
NPI 1720503972 · MORGANTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,070 in 106 payments from 24 companies in 2025. Trend: 2023 $2,462 · 2024 $2,966 · 2025 $2,070
Food & beverage: $1,959Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $492 |
| AstraZeneca Pharmaceuticals LP | 12 | $238 |
| Lilly USA, LLC | 10 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $147 |
| ABBVIE INC. | 9 | $143 |
| Lundbeck LLC | 6 | $142 |
| Vanda Pharmaceuticals Inc. | 4 | $113 |
| Ardelyx, Inc. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Phathom Pharmaceuticals, Inc. | 5 | $61 |
Products named: AUSTEDO XR, REXULTI, CAPLYTA, MOUNJARO, FANAPT, UZEDY, AIRSUPRA, FARXIGA.
Industry payments across NC — which companies pay providers there.
